Company / Current Assets
Editas Medicine, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$163.9M
FY2025
5-year range
$163.9M / $507.3M
FY2021-FY2025
Trend
-43.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 4 consecutive years, from $507M in FY2021 to $164M in FY2025.
Based on SEC 10-K filings.
$164M in FY2025 with a 5-year CAGR of -17.1%.
Declined from $341M to $164M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -22.8%
- 5-Year CAGR
- -17.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Editas Medicine, Inc.'s current assets has declined for 4 consecutive years.
- 5-year CAGR of -17.1%, indicating a declining trend.
- In FY2025, current assets decreased 43.4% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $163.9M | -43.4% |
| FY2024 | $289.3M | -15.1% |
| FY2023 | $340.8M | -4.5% |
| FY2022 | $356.8M | -29.7% |
| FY2021 | $507.3M | +21.1% |
| FY2020 | $419.1M | -9.6% |
| FY2019 | $463.8M | +23.8% |
| FY2018 | $374.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026